Self-reported baseline and clinical characteristics of study subjects, the PLCO Cancer Screening Trial, 1993–2001
Cases (N = 370) | Controls (N = 493) | ||
---|---|---|---|
n (%) or mean (SD) | n (%) or mean (SD) | P | |
Age group, y | |||
≤59 | 83 (22.4) | 98 (19.9) | 0.78 |
60–64 | 127 (34.3) | 170 (34.5) | |
65–69 | 93 (25.1) | 126 (25.6) | |
70–74 | 67 (18.1) | 99 (20.1) | |
Male | 196 (53.0) | 290 (58.8) | 0.09 |
White | 327 (88.4) | 432 (87.6) | 0.74 |
College graduated or higher | 113 (30.6) | 188 (38.4) | 0.02 |
First-degree family history of colorectal cancer | 50 (13.5) | 59 (12.0) | 0.50 |
Current cigarette smoker | 41 (11.1) | 52 (10.6) | 0.86 |
Former cigarette smoker | 162 (43.8) | 225 (45.6) | |
Regular aspirin or ibuprofen use (≥4/mo) | 218 (58.9) | 304 (61.7) | 0.41 |
Current hormone use among females | 88 (44.0) | 112 (50.9) | 0.21 |
Former hormone use among females | 33 (16.5) | 39 (17.7) | |
Body mass index, kg/m2 | 27.5 (4.6) | 27.5 (5.0) | 0.87 |
Alcohol, g/d | 13.8 (29.4) | 11.5 (20.4) | 0.23 |
Natural food folate, μg/d | 302.0 (121.2) | 314.5 (125.8) | 0.17 |
Fortified food folate, μg/d | 163.7 (91.8) | 181.9 (122.3) | 0.02 |
Total folate equivalents (food and supplements), μg/d | 1,056.8 (722.8) | 1,088.8 (727.8) | 0.54 |
Vitamin B6 (food and supplements), mg/d | 2.37 (0.9) | 2.47 (1.1) | 0.16 |
Vitamin B12 (food and supplements), mg/d | 5.7 (3.0) | 5.9 (3.4) | 0.40 |
Methionine (food), g/d | 1.7 (0.7) | 1.7 (0.7) | 0.46 |
Distal carcinoma | 238 (51.5) | ||
Stage I | 82 (16.1) | ||
Stage II | 184 (39.8) | ||
Stage III | 111 (24.0) | ||
Stage IV | 93 (20.1) |